These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25781553)

  • 1. Obesity-related proliferative diseases: the interaction between adipose tissue and estrogens in post-menopausal women.
    Vicennati V; Garelli S; Rinaldi E; Rosetti S; Zavatta G; Pagotto U; Pasquali R
    Horm Mol Biol Clin Investig; 2015 Jan; 21(1):75-87. PubMed ID: 25781553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between menopausal status and obesity in affecting breast cancer risk.
    Rose DP; Vona-Davis L
    Maturitas; 2010 May; 66(1):33-8. PubMed ID: 20181446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase overexpression in dysfunctional adipose tissue links obesity to postmenopausal breast cancer.
    Wang X; Simpson ER; Brown KA
    J Steroid Biochem Mol Biol; 2015 Sep; 153():35-44. PubMed ID: 26209254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular links between obesity and breast cancer.
    Lorincz AM; Sukumar S
    Endocr Relat Cancer; 2006 Jun; 13(2):279-92. PubMed ID: 16728564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and cancer: local and systemic mechanisms.
    Iyengar NM; Hudis CA; Dannenberg AJ
    Annu Rev Med; 2015; 66():297-309. PubMed ID: 25587653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue as target organ in the treatment of hormone-dependent breast cancer: new therapeutic perspectives.
    Macciò A; Madeddu C; Mantovani G
    Obes Rev; 2009 Nov; 10(6):660-70. PubMed ID: 19460113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
    Kaaks R; Lukanova A; Kurzer MS
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1531-43. PubMed ID: 12496040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fat may fuel breast cancer growth.
    Hede K
    J Natl Cancer Inst; 2008 Mar; 100(5):298-9. PubMed ID: 18314468
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
    Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast adipose tissue estrogen metabolism in postmenopausal women with or without breast cancer.
    Savolainen-Peltonen H; Vihma V; Leidenius M; Wang F; Turpeinen U; Hämäläinen E; Tikkanen MJ; Mikkola TS
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2661-7. PubMed ID: 25215559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression.
    Bhardwaj P; Au CC; Benito-Martin A; Ladumor H; Oshchepkova S; Moges R; Brown KA
    J Steroid Biochem Mol Biol; 2019 May; 189():161-170. PubMed ID: 30851382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogenic microenvironment generated by organochlorine residues in adipose mammary tissue modulates biomarker expression in ERalpha-positive breast carcinomas.
    Muñoz-de-Toro M; Durando M; Beldoménico PM; Beldoménico HR; Kass L; García SR; Luque EH
    Breast Cancer Res; 2006; 8(4):R47. PubMed ID: 16859517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When fat becomes an ally of the enemy: adipose tissue as collaborator in human breast cancer.
    Lapeire L; Denys H; Cocquyt V; De Wever O
    Horm Mol Biol Clin Investig; 2015 Jul; 23(1):21-38. PubMed ID: 26154196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular matrix in obesity - cancer interactions.
    Barreto SC; Hopkins CA; Bhowmick M; Ray A
    Horm Mol Biol Clin Investig; 2015 May; 22(2):63-77. PubMed ID: 25870970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper abdominal obesity, insulin resistance and breast cancer risk.
    Stoll BA
    Int J Obes Relat Metab Disord; 2002 Jun; 26(6):747-53. PubMed ID: 12037643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation, dysregulated metabolism and aromatase in obesity and breast cancer.
    Zahid H; Simpson ER; Brown KA
    Curr Opin Pharmacol; 2016 Dec; 31():90-96. PubMed ID: 27875786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary: weight gain, weight loss, and endometrial cancer.
    Webb PM
    Int J Epidemiol; 2006 Feb; 35(1):166-8. PubMed ID: 16394116
    [No Abstract]   [Full Text] [Related]  

  • 20. The midlife transition and the risk of cardiovascular disease and cancer Part I: magnitude and mechanisms.
    Kase NG; Gretz Friedman E; Brodman M; Kang C; Gallagher EJ; LeRoith D
    Am J Obstet Gynecol; 2020 Dec; 223(6):820-833. PubMed ID: 32497614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.